Health Care Select Sector SPDR Fund (XLV) News Today

$143.87
+0.42 (+0.29%)
(As of 03:39 PM ET)
Hims & Hers Health Stock Could Become a Wealth Compounder (XLV)
Hims & Hers stock could give investors the best of both stability and double-digit upside through EPS projections and price targets, especially after 1Q24
CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens? (XLV)
CVS stock is making its way above Walgreens as a potential watchlist addition. Fundamentals and price targets see the stock making a comeback this year.
Capturing Consumer Spending on Health Care with XLV
3 Biotech Stocks Set to Double by 2028
Citi’s Results Say This About The Stock Market (XLV)
Investors now have an inside look at what one of Wall Street's biggest names is doing with its money. Corporations and clients all see new highs in stocks
3 High Dividend Stocks to Replace Lower Savings Yields Ahead (XLV)
Three stocks stand out as the most attractive dividend propositions, particularly now that savings yields may drop as a result of the Fed's rate cuts
Nvidia's AI Tech Part of Novo Nordisk's New Supercomputer (XLV)
Novo Nordisk and Nvidia have teamed up to develop supercomputers, aiming to accelerate drug discovery development using advanced AI technologies.
Health Care Select Sector SPDR ETF
Health Care Select Sector SPDR Fund (XLV)
bluebird bio Stock Signals Potential to be a Multi-bagger (XLV)
Driving a bargain of a short squeeze play, Bluebird Bio stock could soon announce what every investor is hoping to hear, here's what management could do
bluebird bio stock is ripe for a 400% institutional short squeeze (XLV)
Bluebird Bio stock could be on the verge of a 400% pop on earnings, management has set the writing on the wall for institutional buying to trickle in
The 3 Hottest Healthcare ETFs to Buy in 2024
Stocks have been volatile: Here's what has been working
S&P 500 rockets to new highs as earnings beat estimates (XLV)
The S&P 500 hits new highs as 10 of the 11 S&P sectors report positive Q4 earnings surprises. The tech and energy sectors are among the earnings leaders.
Can financial, healthcare, energy stocks rise as rates stay high? (XLV)
Sectors including financials, healthcare, utilities and energy outperform as interest rates remain high, but some of those industries face challenges in 2024.
Markets suddenly price Eli Lilly stock for a breakout on earnings (XLV)
The healthcare sector could see a sudden inflow of investment dollars, and Eli Lilly quickly becomes a favorite name in the space as markets and analysts bid up
Pfizer’s earnings growth trade at a deep discount, suddenly a buy (XLV)
The healthcare sector is set to attract a new inflow of investment dollars, as seen in business activity and employment. Pfizer is the clear sector favorite
5 top healthcare stocks for earnings growth in 2024 (XLV)
2024 holds promise for healthcare stocks, with Humana, Elevance, and others expected to boost earnings, as analysts say many industry pressures have been removed.
Dow, S&P 500 extend gains: How global markets are moving
Are CVS store closures prescription for better financial health? (XLV)
CVS plans to close dozens of Target pharmacies starting in February. Amid retail pharmacy challenges, CVS is shifting toward the managed-care industry.
UnitedHealth's rising premiums could cushion stubborn inflation (XLV)
The healthcare sector is one of the prime suspects to attract safety-seeking investors in the coming market shift. Within it, THIS stock can prove a winner
AstraZeneca: Rebound in 2024 with double-digit earnings growth (XLV)
AstraZeneca's stock rose 8.95% in the past month on a bullish outlook, driven by growing sales of cancer and diabetes drugs and a strategic acquisition
Healthcare ETF (XLV) Hit a 52-Week High
HCA Healthcare Rallies: Weight-loss drugs really a big threat? (XLV)
HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges.
Are defensive sectors ready to outshine growth in 2024? (XLV)
Is 2024 the year defensive stocks rotate into leadership? As the year gets underway, defensives such as healthcare, energy, utilities and consumer staples lead.
3 Biotech Stocks Set for Breakthroughs in 2024
Align Technology: Protected by more factors than any other stock (XLV)
Jobs are flowing to the healthcare space, and investment dollars are finding a home in stocks like Align Technology, even the CEO thought it to be the best
Pfizer's chaotic year wraps up with plunging stock, grim guidance (XLV)
Pfizer's tumultuous 2023 included a 41.84% stock plunge as revenue from Covid drugs fell. Disappointing 2024 guidance resulted in analysts slashing targets.
6 best healthcare stocks to buy now (XLV)
Whether you invest in healthcare stocks for pharmaceuticals, medical devices or health insurance, the opportunities are limitless. Learn more with MarketBeat.
5 best healthcare sector ETFs (XLV)
What do you need to know about investing in healthcare ETFs? Learn more about both healthcare and ETFs with MarketBeat.
Mega merger in the works? Humana, Cigna explore big deal (XLV)
Humana and Cigna are exploring a merger, aiming to conclude the deal before year-end, creating a healthcare giant with a potential market value of $137 billion.
These are the top sectors for blue chip growth in 2024 (XLV)
The sector results will be mixed in 2024 but the Health Care, Communications and Technology sectors (and some of their stocks) will post robust gains.
J&J, Gilead, BMS: A look at undervalued dividend payers (XLV)
J&J, Gilead and Bristol Myers are among healthcare stocks with defensive qualities amid market volatility and a potential economic slowdown
Analysis: Why healthcare stocks underperformed in 2023
Get Health Care Select Sector SPDR Fund News Delivered to You Automatically

Sign up to receive the latest news and ratings for XLV and its competitors with MarketBeat's FREE daily newsletter.

Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)

Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.

Click here if you’d like to learn more about these five cryptos…

XLV Media Mentions By Week

XLV Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

XLV
News Sentiment

1.21

0.96

Average

News Sentiment

XLV News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

XLV Articles
This Week

1

1

XLV Articles
Average Week

Get Health Care Select Sector SPDR Fund News Delivered to You Automatically

Sign up to receive the latest news and ratings for XLV and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSEARCA:XLV) was last updated on 5/14/2024 by MarketBeat.com Staff

From Our Partners